Wuhan Easy Diagnosis Biomedicine002932 
$2.210.19%24h
0.19%24h
Global rank11256
Market cap$514.25M
Change 7d-4.57%
YTD Performance-31.94%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Wuhan Easy Diagnosis Biomedicine (002932)
As of November 2024, Wuhan Easy Diagnosis Biomedicine has a market cap of $514.25M. This makes Wuhan Easy Diagnosis Biomedicine the world's 11256th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Wuhan Easy Diagnosis Biomedicine from 2018 to 2024
-
Value:-
Market cap history of Wuhan Easy Diagnosis Biomedicine from 2018 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $611.13M | -18.98% |
| 2023 | $754.30M | -59.89% |
| 2022 | $1.88B | -22.61% |
| 2021 | $2.43B | 64.34% |
| 2020 | $1.48B | 74.10% |
| 2019 | $849.35M | -17.93% |
| 2018 | $1.03B | - |
002932 Market Cap Today is $514.25M 0.19% - 3 Nov 2024
View largest stocks by market cap 
